Cytiva claims the installation of its FlexFactory facilities will provide ForecyteBio with access to platforms to manufacture viral vectors and plasmid DNA for the US and Chinese markets. Cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) ForcecyteBio will begin the collaboration at Cytiva’s Fast Trak center located in Shanghai, China. “Cytiva‘s Fast Trak Center will consult on process design and development, GMP production platform development, and talent building and training,” a spokesperson for Cytiva told BioProcess Insider.…